ANGIODYNAMICS INC Quarterly Common Stock, Shares Authorized from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Angiodynamics Inc quarterly Common Stock, Shares Authorized history and growth rate from Q2 2011 to Q3 2024.
  • Angiodynamics Inc Common Stock, Shares Authorized for the quarter ending August 31, 2024 was 75M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 75M 0 0% Aug 31, 2024 10-Q 2024-10-03
Q2 2024 75M 0 0% May 31, 2024 10-Q 2024-10-03
Q1 2024 75M 0 0% Feb 29, 2024 10-Q 2024-04-09
Q4 2023 75M 0 0% Nov 30, 2023 10-Q 2024-01-08
Q3 2023 75M 0 0% Aug 31, 2023 10-Q 2023-10-05
Q2 2023 75M 0 0% May 31, 2023 10-K 2024-07-25
Q1 2023 75M 0 0% Feb 28, 2023 10-Q 2023-03-31
Q4 2022 75M 0 0% Nov 30, 2022 10-Q 2023-01-06
Q3 2022 75M 0 0% Aug 31, 2022 10-Q 2022-10-11
Q2 2022 75M 0 0% May 31, 2022 10-K 2023-08-03
Q1 2022 75M 0 0% Feb 28, 2022 10-Q 2022-04-07
Q4 2021 75M 0 0% Nov 30, 2021 10-Q 2022-01-07
Q3 2021 75M 0 0% Aug 31, 2021 10-Q 2021-09-30
Q2 2021 75M 0 0% May 31, 2021 10-K 2022-07-22
Q1 2021 75M 0 0% Feb 28, 2021 10-Q 2021-03-31
Q4 2020 75M 0 0% Nov 30, 2020 10-Q 2021-01-08
Q3 2020 75M 0 0% Aug 31, 2020 10-Q 2020-10-07
Q2 2020 75M 0 0% May 31, 2020 10-K 2021-07-27
Q1 2020 75M 0 0% Feb 29, 2020 10-Q 2020-04-08
Q4 2019 75M 0 0% Nov 30, 2019 10-Q 2020-01-08
Q3 2019 75M 0 0% Aug 31, 2019 10-Q 2019-10-04
Q2 2019 75M 0 0% May 31, 2019 10-K 2020-08-10
Q1 2019 75M 0 0% Feb 28, 2019 10-Q 2019-04-02
Q4 2018 75M 0 0% Nov 30, 2018 10-Q 2019-01-07
Q3 2018 75M 0 0% Aug 31, 2018 10-Q 2019-04-02
Q2 2018 75M 0 0% May 31, 2018 10-K 2019-07-25
Q1 2018 75M 0 0% Feb 28, 2018 10-Q 2018-04-05
Q4 2017 75M 0 0% Nov 30, 2017 10-Q 2018-01-05
Q3 2017 75M 0 0% Aug 31, 2017 10-Q 2017-09-29
Q2 2017 75M 0 0% May 31, 2017 10-K 2018-07-23
Q1 2017 75M 0 0% Feb 28, 2017 10-Q 2017-04-03
Q4 2016 75M 0 0% Nov 30, 2016 10-Q 2017-01-06
Q3 2016 75M +30M +66.7% Aug 31, 2016 10-Q 2016-10-05
Q2 2016 75M 0 0% May 31, 2016 10-K 2017-08-04
Q1 2016 75M +30M +66.7% Feb 29, 2016 10-Q 2016-04-11
Q4 2015 75M +30M +66.7% Nov 30, 2015 10-Q 2016-01-08
Q3 2015 45M -30M -40% Aug 31, 2015 10-Q 2015-10-08
Q2 2015 75M +30M +66.7% May 31, 2015 10-K 2016-08-01
Q1 2015 45M 0 0% Feb 28, 2015 10-Q 2015-04-09
Q4 2014 45M 0 0% Nov 30, 2014 10-Q 2015-01-09
Q3 2014 75M +30M +66.7% Oct 29, 2014 10-K 2024-07-25
Q2 2014 45M 0 0% May 31, 2014 10-K 2015-08-10
Q1 2014 45M 0 0% Feb 28, 2014 10-Q 2014-04-09
Q4 2013 45M 0 0% Nov 30, 2013 10-Q 2014-01-09
Q3 2013 45M 0 0% Aug 31, 2013 10-Q 2013-10-10
Q2 2013 45M 0 0% May 31, 2013 10-K/A 2015-01-12
Q1 2013 45M 0 0% Feb 28, 2013 10-Q 2013-04-09
Q4 2012 45M 0 0% Nov 30, 2012 10-Q 2013-01-09
Q3 2012 45M 0 0% Aug 31, 2012 10-Q/A 2012-11-09
Q2 2012 45M 0 0% May 31, 2012 10-K 2013-08-14
Q1 2012 45M Feb 29, 2012 10-Q 2012-04-09
Q4 2011 45M Nov 30, 2011 10-Q 2012-01-05
Q3 2011 45M Aug 31, 2011 10-Q 2011-10-11
Q2 2011 45M May 31, 2011 10-K 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.